Clinical Edge Journal Scan

Clinical Edge Journal Scan

Commentary: Combination therapies and immunotherapy in HCC, December 2022

Publish date: November 29, 2022

• Read More

Clinical Edge Journal Scan

Aspirin use confers multifaceted benefits in HCC

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

Microwave ablation: An alternative to resection in HCC with BCLC stage 0

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

Sequence of radiotherapy and TACE affects the prognosis of HCC with portal vein tumor thrombus

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

Atezolizumab+bevacizumab: A better first-line treatment option for unresectable HCC than lenvatinib

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

Alpha-fetoprotein and carbohydrate antigen 19-9: Prognostic markers in HCC after hepatectomy

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

HAIC+lenvatinib+sequential ablation: An effective and safe treatment option for advanced HCC

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

HCC: Atezolizumab+bevacizumab treatment outcome unaffected by the underlying liver etiology

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

Immune checkpoint inhibitor rechallenge is effective and safe in HCC

Publish date: November 18, 2022

• Read More

Clinical Edge Journal Scan

Bevacizumab use is questionable in liver cirrhosis with locally advanced HCC

Publish date: November 18, 2022

• Read More

Pages

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• last »